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Abstract cAMP represses the transcription of some Saccharo-
myces cerevisiae genes sensitive to catabolite repression. The
effect of cAMP on the expression of FBP1, encoding fructose-
1,6-bisphosphatase (FbPase), has been further investigated. In
yeast cells shifted to a derepressing medium, synthesis of FbPase
was delayed if the strong decrease in intracellular cAMP, which
occurs during the shift, was prevented. A similar delay occurred
in a RAS2val19 strain, while in a tpk1w strain, with weak protein
kinase A activity, induction of FbPase occurred earlier than in a
TPK1 strain. In the tpk1w strain, proteins which bind the UAS1
element of FBP1 were present during growth on glucose but they
were only weakly operative. Expression of CAT8 and SIP4,
encoding proteins which bind the UAS2 element, was blocked by
a high concentration of cAMP, but catabolite repression of these
genes was not much relieved in a tpk1w strain. We conclude that
in S. cerevisiae, as reported for Schizosaccharomyces pombe,
control of FBP1 requires both cAMP-dependent and independent
pathways; however, the mechanisms operating in the two yeasts
are different. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
To avoid the simultaneous functioning of enzymes catalyz-
ing antagonistic reactions, elaborate regulatory mechanisms
have evolved and have been selected in di¡erent organisms.
A well-documented case is that of antagonistic enzymes in-
volved in glycolysis and gluconeogenesis. Genes encoding glu-
coneogenic enzymes are usually repressed by glucose and
cAMP appears implicated in di¡erent ways in the control of
these genes.
In Escherichia coli and in mammalian cells, where cAMP
concentration falls when glucose is available [1], induction of
the genes which encode phosphoenolpyruvate carboxykinase
requires cAMP [2,3]. However, if glucose is present the genes
are not induced even at a high concentration of cAMP [2,4].
In contrast, in yeasts, which show high levels of cAMP
during growth on glucose [5], the expression of the genes
which encode the gluconeogenic enzyme fructose-1,6-bisphos-
phatase (FbPase) is negatively regulated by cAMP. In Schizo-
saccharomyces pombe, any mutation which impairs cAMP-de-
pendent protein kinase activity allows the derepression of the
fbp1 gene in the presence of glucose [6,7]. In addition, fbp1
expression depends on a pathway which includes the mitogen-
activated protein kinase Sty1, the Wis1 kinase acting on Sty1
and a protein tyrosine phosphatase, Pyp1, able to dephos-
phorylate and inactivate Sty1. Both Wis1 and Sty1 are re-
quired for fbp1 expression while overexpression of pyp1
inhibits the transcription of fbp1 [8^10]. In Saccharomyces
cerevisiae, although genes such as those encoding galactoki-
nase [11] or invertase [12] are not a¡ected by cAMP, cAMP
has been shown to interfere with the transcription of a large
number of genes normally expressed at the diauxic shift [13],
and it has been observed that cAMP is able to block the
expression of the FBP1 gene in a derepressing medium [12,14].
The promoter of FBP1 from S. cerevisiae contains two
activating elements, UAS1 and UAS2, which both show car-
bon source-dependent regulation [15^18], and respond, to dif-
ferent extents, to the presence of cAMP [12]. To explore fur-
ther the e¡ect of cAMP on the control of FBP1, we have
studied how mutations in the cAMP signaling pathway, which
may cause either an increase or a decrease in protein kinase
activity dependent on cAMP, a¡ect FBP1 expression or the
formation of UASFBP1^DNA complexes. We have also exam-
ined how do changes in the cAMP signaling pathway a¡ect
the expression of the genes CAT8 and SIP4, which encode
two zinc cluster proteins, Cat8 and Sip4, both able to bind
UAS2 [19,20], but which regulate di¡erently the activating
elements UAS1 and UAS2 [21].
2. Materials and methods
2.1. Yeast strains and growth conditions
Yeasts strains used in this study are listed in Table 1. Yeasts were
grown at 30‡C or at 24‡C (cdc25 pde2 strains) in YPD (1% yeast
extract, 2% peptone, 2% glucose), in Difco yeast nitrogen base
(YNB) or in a synthetic complete medium (SC) [22] with 2% glucose,
and collected at the exponential phase of growth, 2^3 mg wet weight/
ml (repressed cells). To obtain derepressed cells, glucose-grown yeasts
were washed twice with distilled water, suspended at 20 mg/ml in YP
2% ethanol and incubated for the time indicated in each case, at 30‡C
or at 24‡C (cdc25 pde2 strains). The media to which cAMP was added
were sterilized by ¢ltration. To isolate transformed pde2 strains an
enriched minimal medium (YNBS) was used [13].
2.2. Plasmids
Plasmids containing UAS1-lacZ and UAS2-lacZ fusion genes have
been described previously [18] as well as CYC1-lacZ (pLG669-Z) [23],
CAT8-lacZ (pDG225) [17] and pSIP4-lacZ [24]. pPDE2 contains a
5.1-kb BamHI^HindIII fragment from pW34 [25] with the complete
PDE2 gene under the control of its own promoter within the centro-
meric plasmid YCplac111 [26]. pRAS2val19 contains the mutated
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RAS2val19 under the control of its own promoter (F. Portillo, unpub-
lished) and is derived from YEp351 [27]. To construct strain LOZ179,
a GLK1-lacZ fusion gene was integrated in the URA3 locus from
OL556 by linearizing plasmid YIp944 [28] with StuI.
Cloning procedures were performed according to standard proto-
cols [29]. Yeast cells were transformed using the lithium acetate meth-
od [30] with minor modi¢cations.
2.3. Preparation of extracts and enzymatic tests
Yeast extracts were prepared by shaking with glass beads as de-
scribed in [31]; for L-galactosidase assays the centrifugation step was
omitted. L-Galactosidase was assayed as in [32], the samples being
centrifuged before reading their absorbance. FbPase was tested spec-
trophotometrically as described in [33]. Protein was determined using
the BCA protein assay (Pierce) with bovine serum albumin as a stan-
dard.
2.4. Western and Northern blot analysis
Yeast cell-free extracts were precipitated with 2 Vol of 15% tri-
chloroacetic acid and resuspended in Laemmli bu¡er [34] at a ¢nal
concentration of 1.5 mg/ml. Samples were heated 5 min at 95‡C, frac-
tionated in a sodium dodecyl sulfate (SDS)^10% polyacrylamide gel,
and the proteins transferred to a nitrocellulose membrane by semidry
blotting, using 25 mM Tris base, 190 mM glycine and 20% methanol.
Anti-FbPase antibodies [33] diluted 1/50 000 in blocking bu¡er and
goat anti-rabbit peroxidase conjugate (Biosource International, Ca-
marillo, CA, USA) diluted 1/10 000 were used as primary and second-
ary antibody, respectively. The ECL kit from Amersham was used to
visualize the immunoprecipitates.
Total RNA was extracted as described in [35] using the Gibco
Trizol reagent and the RNA samples treated as described [36]. As
probe for the Northern blot, we used a 0.82-kb EcoRV^StuI fragment
of the FBP1 gene, from position +57 to +877. The probe was labeled
as in [37] using the Pharmacia labeling kit.
2.5. Determination of cAMP
Yeast cells were collected by rapid ¢ltration, frozen in liquid nitro-
gen and extracted with boiling ethanol, as described in [38]. cAMP
was determined in the extracts by a competition assay [5] using the
Amersham kit.
2.6. Preparation of yeast nuclear extracts and band-shift assays
Nuclear extracts were obtained as described in [39]. Band-shift as-
says were performed as described previously, using oligonucleotides
OL1 and OL2 which correspond to UAS2FBP1 and UAS1FBP1 respec-
tively [16].
3. Results and discussion
3.1. Mutations in the cAMP-dependent protein kinase pathway
a¡ect the expression of FBP1 and the formation of
DNA^protein complexes with UAS1
We have studied how the kinetics of FbPase derepression
change in the presence of mutations which a¡ect the cAMP
signaling pathway. Since these kinetics show large variations
in di¡erent genetic backgrounds (reference strains in Figs. 1
and 2 and results not shown), it is important to test always a
congenic strain as a control. In a pde2 strain, the absence of
the high a⁄nity phosphodiesterase would be expected to
damp changes in intracellular cAMP after the shift of yeast
cells to a medium lacking glucose. As shown in Fig. 1A, in
such a pde2 strain derepression was delayed with respect to
that of the mutant yeast transformed with a plasmid contain-
ing the PDE2 gene. Little FbPase activity was present 2 h
after the shift to derepressing medium. To investigate if this
Table 1
S. cerevisiae strains used in this work
Strain Relevant genotype Source/reference
W303-1A MATa ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 [41]
OL556 MATa/MATKcdc25-5/cdc25-5 his3/his3 leu2/leu2 rca1(pde2)/rca1 TRP1/trp1 ura3/ura3 [13]
LOZ179 MATa/MATKcdc25-5/cdc25-5 his3/his3 leu2/leu2 rca1(pde2)/rca1 TRP1/trp1 ura3/ura3: : GLK1-lacZ-URA3 this study
JF907 MATa ade8 his3 leu2 trp1 ura3: : GSY2-lacZ-URA3 tpk1w tpk2: :HIS3 tpk3: :TRP1 bcy1: :LEU2
snf1: :ADE8
J.M. Franc°ois
JF908 MATa ade8 his3 leu2 trp1 ura: : GSY2-lacZ-URA3 tpk1w tpk2: :HIS3 tpk3: :TRP1 bcy1: :LEU2 J.M. Franc°ois
S7-7A MATa ade8 his3 leu2 trp1 ura3 tpk2: :HIS3 tpk3: :TRP1 [42]
S18-1D MATK ade8 his3 leu2 trp1 ura3 tpk1w tpk2: :HIS3 tpk3: :TRP1 [42]
Fig. 1. E¡ect of the lack of Pde2 in the kinetics of expression of FBP1. S. cerevisiae OL556 (pde2) transformed with a control plasmid (U) or
with a plasmid containing the PDE2 gene (b) was grown in YNBS glucose and derepressed in YP ethanol. A: FbPase activity was measured
as described in Section 2 in samples taken at the times indicated. D: cAMP was determined as described in Section 2 in samples taken just be-
fore transferring the cells into YP ethanol (marked as glucose with an arrow) and after the transfer, at the times indicated. B: Western blot
and C: Northern blot of the di¡erent samples.
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low FbPase activity in the mutant was due to an e¡ect on
gene transcription or to catabolite inactivation of the enzyme,
we performed Western and Northern analysis in the pde2
strain. Neither protein reactive with speci¢c antibodies nor
mRNA corresponding to FBP1 were detected (Fig. 1B, C).
These ¢ndings suggest that the observed e¡ect took place at
the transcriptional level. When the yeast with an intact PDE2
gene, growing exponentially in glucose, was washed and re-
suspended in a derepressing medium, there was a strong de-
crease in the intracellular cAMP concentration, which was
Fig. 2. E¡ect of di¡erent mutations in the cAMP signaling pathway on the derepression of FbPase. A: S. cerevisiae W303-1A transformed
with a control plasmid (b) or with a plasmid containing the RAS2val19 gene (U) was grown in YNB glucose and derepressed in YP ethanol.
B: Strains S7-7A (TPK1) and S18-1D (tpk1w) were grown in SC glucose and derepressed in YP ethanol. At the times indicated samples were
taken and FbPase activity was measured in the corresponding extracts.
Fig. 3. E¡ect of a low level of cAMP-dependent protein kinase on the DNA^protein complexes formed with UAS sequences from FBP1. Nu-
clear protein extracts were prepared from strains S7-7A (TPK1), S18-1D (tpk1w), JF907 (tpk1wbcy1snf1) or JF908 (tpk1wbcy1) grown on YPD
(Glu) or derepressed in YP ethanol (Et). A: The oligonucleotide OL2 corresponding to UAS1FBP1 was used as probe and 20 Wg of nuclear pro-
teins were added to the samples in lanes 2^9 and 11^14. B: The oligonucleotide OL1 corresponding to UAS2FBP1 was used as probe and 40 Wg
of nuclear proteins were added to the samples in lanes 2^9. When indicated, a 100-fold excess of competitor DNA was used. See Section 2 for
further details. Speci¢c complexes are indicated with arrows.
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followed by a gradual recovery (Fig. 1D). In the mutant the
decrease was much less marked, but after 2 h in the derepress-
ing conditions, the cAMP levels became similar to those of the
wild-type yeast. We conclude that a marked decrease in the
intracellular concentration of cAMP appears to facilitate the
derepression of FbPase, but is not an absolute requirement
for it.
In a yeast strain overexpressing the gene RAS2val19, cAMP
levels should be increased and, as expected, FbPase derepres-
sion is strongly impaired in such a strain (Fig. 2A). On the
other hand, in a strain with a weak protein kinase A activity
(tpk1w strain), FbPase derepression took place much earlier
than in the equivalent strain with a wild-type TPK1 gene (Fig.
2B). In all strains, FbPase activity reached high levels after an
overnight incubation in YP ethanol.
The formation of UAS1FBP1^protein complexes in band-
shift experiments is reduced when nuclear extracts from cells
derepressed in the presence of cAMP are used [12]. It would
be possible that, conversely, in a tpk1w strain the formation of
UAS1FBP1^protein complexes may occur even when nuclear
extracts from glucose-grown cells are used, in contrast with
the situation in a wild-type strain. As shown in Fig. 3A, in
tpk1w strains (either with an intact or an interrupted BCY1
gene) UAS1^protein complexes were formed with extracts
from repressed cells. The complexes were also found in a mu-
tant lacking Snf1, a protein kinase required for the expression
of UAS1-binding proteins, in a wild-type strain, under dere-
pressed conditions [16]. This suggests that the requirement for
Snf1 observed earlier is related to the need to counteract the
activity of the cAMP-dependent protein kinases. On the other
hand, the UAS2^protein complex was not formed when ex-
tracts from a glucose-grown tpk1w strain were used (Fig. 3B).
Thus, a decreased activity of the cAMP-dependent protein
kinase does not relieve the repression of proteins binding
UAS2, but allows the formation of UAS1^protein complexes
in glucose-grown cells. However, the formation of this com-
plex is not su⁄cient to obtain a measurable FbPase activity in
the same conditions ([12], Fig. 2B). Moreover, the UAS1^
protein complexes formed with extracts from a glucose-grown
tpk1w strain operate poorly. As shown in Table 2, in such a
strain the expression of UAS1-lacZ was still strongly re-
pressed by glucose, as happens with that of UAS2-lacZ (Table
2). However derepression of FbPase occurs earlier in a tpk1w
strain than in the corresponding TPK1 strain (Fig. 2B) and
the same happens with derepression of UAS2-lacZ (results not
shown).
3.2. E¡ect of cAMP on the expression of CAT8 and SIP4
Since it has been found that cAMP a¡ects the expression of
UAS1-lacZ and UAS2-lacZ [12], we investigated whether
cAMP could act by regulating the transcription of CAT8
and SIP4. We tested the expression of CAT8-lacZ and
SIP4-lacZ in a tpk1w strain with the results shown in Table
2. During growth on glucose, the amount of L-galactosidase
synthesized from CAT8-lacZ was markedly higher than in the
TPK1 strain, indicating that the expression of CAT8 is re-
pressed by glucose through a cAMP-dependent pathway.
However, the relief of CAT8 repression in the tpk1w is only
partial, since the L-galactosidase activity measured in glucose
is 40-fold lower than the one measured in the same strain in
ethanol (8100 mU/mg protein), a result which supports the
idea of redundant glucose repression pathways. In the case
of SIP4-lacZ, there was only a small di¡erence between the
two strains.
On the other hand, using a pde2 mutant, sensitive to exter-
nal cAMP, we found that derepression of SIP4-lacZ in the
presence of ethanol was completely blocked by cAMP and
that derepression of CAT8-lacZ was also strongly a¡ected
(Table 3). The lack of expression of the fusion genes in the
presence of cAMP cannot be explained by a strong inhibition
of protein synthesis by cAMP, since in these conditions the
control plasmids CYC1-lacZ and GLK1-lacZ (Table 3) and
UAS2-lacZ [12] can still direct the synthesis of L-galactosi-
dase.
3.3. Conclusions
We can conclude that cAMP plays a role in glucose signal-
ing towards FBP1, but appears to be redundant with other
regulatory mechanisms [12]. A decrease in cAMP levels would
facilitate the transition from growth on fermentable carbon
sources to growth on non-fermentable ones, but the block of
FBP1 derepression by cAMP would only be temporary. It is
interesting to remark that when yeast cells are transferred
from a poor to a rich carbon source the reverse situation
occurs. A sugar, such as glucose, induces a transient increase
in cAMP levels which activates the cAMP-dependent protein
kinases; in mutant strains, where this increase does not take
place, there is an extended delay in the resumption of growth
[40].
In S. pombe derepression of the fbp1 gene is not only
controlled by cAMP, but depends on the protein kinases
Wis1 and Sty1, and is negatively regulated by the protein
tyrosine phosphatase, Pyp1 [8^10]. In contrast, we have ob-
served that expression of S. cerevisiae FBP1 is not a¡ected by
Table 2
Expression of fusion genes in yeast strains with a weak protein ki-
nase A activity (tpk1w)
Fusion gene L-Galactosidase (mU/mg protein)
TPK1 tpk1w
UAS1-lacZ 19 þ 1 96 þ 7
UAS2-lacZ 9 þ 1 47 þ 7
CAT8-lacZ 7 þ 1 160 þ 60
SIP4-lacZ 9 þ 1 23 þ 9
Yeast strains S7-7A (TPK1) or S18-1D (tpk1w) transformed with
plasmids pOV30n (UAS1-lacZ), pOV21i (UAS2-lacZ), pDG225
(CAT8-lacZ) or pSIP4-lacZ were grown in SC glucose medium and
collected in the logarithmic phase of growth. The values of L-galac-
tosidase activity represent the mean values of three independent
transformants.
Table 3
E¡ect of cAMP on the expression of CAT8 and SIP4
Fusion gene L-Galactosidase (mU/mg protein)
Glucose Ethanol Ethanol+cAMP
CAT8-lacZ 6 2 1420 þ 190 39 þ 11
SIP4-lacZ 6 2 110 þ 27 4 þ 2
CYC1-lacZ 610 þ 110 1130 þ 120 1100 þ 115
GLK1-lacZ 31 þ 1 1535 þ 47 351 þ 20
S. cerevisiae OL556 (pde2) transformed with di¡erent plasmids,
pDG225, pSIP4-lacz, pLG669-Z and YIp944 (see Section 2) was
grown in YPD and derepressed for 12 h in YP ethanol in the ab-
sence or the presence of 5 mM cAMP. Data are the mean of at
least three di¡erent transformants þ the standard deviation.
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the lack of the kinases homologous to Wis1 and Sty1 (Pbs2
and Hog1) or by overexpression of the protein tyrosine phos-
phatase Ptp2 (J.M. Gancedo, unpublished results). It seems
therefore that, although in two widely divergent yeast species
there is a tight control of the gene encoding FbPase, which
involves the interplay of a cAMP-dependent pathway with
other regulatory mechanisms, in each yeast the mechanisms
which have been selected for are di¡erent.
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